VIVA

Healio brings you the highlights from the Vascular Intervention Advances Scientific Session. Refer back to this page often for the latest news from VIVA, perspectives and interviews with leading researchers and clinicians, and to review archives of past meetings.
Meeting News

Novel DCB improves Rutherford class, other outcomes at 1 year

November 14, 2018
LAS VEGAS — A novel drug-coated balloon conferred improvement in Rutherford class, ankle-brachial index and several measures of walking ability…
Meeting NewsPerspective

DETOUR I: 18-month results encouraging for percutaneous bypass system

November 9, 2018
LAS VEGAS — A fully percutaneous bypass system using the femoral vein as a conduit benefited patients with long superficial femoral artery…
Meeting News

DCB shows benefit at 6 months for below-the-knee lesions

November 8, 2018
LAS VEGAS — Anticipated results of the Lutonix BTK study highlighted superior efficacy and similar safety through 6 months with a drug-coated…
Meeting NewsVideo

VIDEO: A 'new wave of innovation' for CLI

November 8, 2018
LAS VEGAS — In this video exclusive, Jihad A. Mustapha, MD, FACC, FSCAI, highlights results of the anticipated Lutonix BTK study showing…
Meeting News

Implant successfully repairs dissections caused by angioplasty

November 7, 2018
LAS VEGAS — An endovascular implant used to repair dissections caused by plain or drug-coated balloons during angioplasty in peripheral…
Meeting News

Interim data show benefit of 3D helical vascular stent

November 7, 2018
LAS VEGAS — Interim data from the MIMICS-3D registry demonstrated early safety and effectiveness of a 3D helical vascular stent in challenging…
Meeting NewsPerspective

Global peripheral DES analysis identifies predictors of TLR

November 6, 2018
LAS VEGAS — In a pooled analysis of five global studies of the Zilver PTX drug-eluting stent in challenging patient populations, a high rate of…
Meeting NewsPerspective

DCB remains superior to PTA at 5 years

November 6, 2018
LAS VEGAS — A drug-coated balloon conferred a lower rate of clinically driven target lesion revascularization at 5 years compared with…
Meeting News

Women, men have similar patency outcomes after DCB treatment

November 6, 2018
LAS VEGAS — Despite older age and worse vessel and lesion characteristics, women with peripheral artery disease treated with the Stellarex…
Meeting NewsPerspective

Peripheral DES safe, effective in long lesions: IMPERIAL substudy

November 6, 2018
LAS VEGAS — A peripheral drug-eluting stent was as safe and effective in long lesions as it was in shorter lesions, according to late-breaking…

Meeting Calendar

VIVA

November 5, 2018 - November 8, 2018